Analysis of the transcriptome of peripheral blood cells from 246 healthy controls and patients with COVID-19 shows expression of FV, and expression is increased in patients with more severe disease for at least 72 days after onset of symptoms (Figure 1A). This evidence concerns the gene F5 and COVID-19.